FOLFOXIRI-Bevacizumab Regimen

Preferred Label : FOLFOXIRI-Bevacizumab Regimen;

NCIt synonyms : Leucovorin-Fluorouracil-Oxaliplatin-Irinotecan Plus Avastin; FOLFOXIRI Plus Avastin; FOLFOXIRI/Avastin Regimen; Folinic Acid/Fluorouracil/Oxaliplatin/Irinotecan Plus Bevacizumab; FOLFOXIRI-Avastin Regimen; FOLFOXIRI Plus Bevacizumab; FOLFOXIRI/Bevacizumab Regimen; Leucovorin/Fluorouracil/Oxaliplatin/Irinotecan/Bevacizumab;

NCIt definition : A regimen consisting of fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFOXIRI), plus bevacizumab that is used for the treatment of colon cancer.;

NCI Metathesaurus CUI : CL523564;

Détails

Origin ID

C136253;

UMLS CUI

C4526526;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Fluorouracil [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Oxaliplatin [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients